# The Effects of Antipsychotic Drugs on Brain Metabolism in Healthy Individuals

> **NCT02536846** · PHASE4 · COMPLETED · sponsor: **Dost Ongur** · enrollment: 35 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Olanzapine

## Key facts

- **NCT ID:** NCT02536846
- **Lead sponsor:** Dost Ongur
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-17
- **Primary completion:** 2019-11-08
- **Final completion:** 2019-11-08
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2022-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02536846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02536846, "The Effects of Antipsychotic Drugs on Brain Metabolism in Healthy Individuals". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02536846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*